StockUS listing USCAHNYSEHealthcareQuality Compounder

Cardinal Health Inc(CAH) Stock Analysis | Healthcare

USD --+0.00%
Reward62Moderate
Risk32Moderate
75%Data
Thin 1% profit margin
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 57.79Bn
Reward Ratingⓘ62 Moderate reward assessment · 75% data coverage
Top 50% of stocksView factors
Risk Ratingⓘ32 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CAH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Cardinal Health Inc?

operates as a healthcare services and products company in the United States and internationally.

AI Brief Pro

The brief on Cardinal Health Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Cardinal Health Inc?

operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 57.79B, and a P/E ratio of 35.3x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (62)

Similar stocks to compare

A short list of Medical Distribution names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Distribution
P/E Ratio35.3499
Beta0.501
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.